January 12, 2004: Additive Benefits of Pravastatin and Aspirin to Decrease Risks of Cardiovascular Disease: Randomized and Observational Comparisons of Secondary Prevention Trials and Their Meta-analyses
Educational Objective: To determine if statins and aspirin have additive effects in the secondary prevention of cardiovascular disease
